BJU International最新文献

筛选
英文 中文
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy. 基于腔内非编码 RNA 的基因组分类器证实,采用根治性膀胱切除术治疗的临床器官局限性膀胱癌患者疗效良好。
IF 3.7 2区 医学
BJU International Pub Date : 2024-11-01 DOI: 10.1111/bju.16572
Joep J de Jong, James A Proudfoot, Siamak Daneshmand, Robert S Svatek, Vikram Naryan, Ewan A Gibb, Elai Davicioni, Shreyas Joshi, Aaron Dahmen, Roger Li, Brant A Inman, Paras Shah, Iftach Chaplin, Jonathan Wright, Yair Lotan
{"title":"A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy.","authors":"Joep J de Jong, James A Proudfoot, Siamak Daneshmand, Robert S Svatek, Vikram Naryan, Ewan A Gibb, Elai Davicioni, Shreyas Joshi, Aaron Dahmen, Roger Li, Brant A Inman, Paras Shah, Iftach Chaplin, Jonathan Wright, Yair Lotan","doi":"10.1111/bju.16572","DOIUrl":"https://doi.org/10.1111/bju.16572","url":null,"abstract":"<p><strong>Objective: </strong>To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non-coding RNA (lncRNA)-based genomic profiling has suggested utility in identifying a distinct tumour subgroup corresponding to a favourable prognosis in patients with bladder cancer.</p><p><strong>Patients and methods: </strong>Transcriptome-wide expression profiling using Decipher Bladder was performed on transurethral resection of bladder tumour samples from a cohort of patients with high-grade, clinically organ-confined (cTa-T2N0M0) urothelial carcinoma (UC) who subsequently underwent RC without any neoadjuvant therapy (n = 226). The lncRNA-based luminal favourable status was determined using a previously developed GC. The primary endpoint was overall survival (OS) after RC. Secondary endpoints included cancer-specific mortality and upstaging at RC.</p><p><strong>Results: </strong>In the study, 134 patients were clinical non-muscle-invasive bladder cancer (cTa/Tis/T1) and 92 patients were cT2. We identified 60 patients with luminal favourable subtype, all of which showed robust gene expression patterns associated with less aggressive bladder cancer biology. On multivariate analysis, patients with the luminal favourable subtype (vs without) were significantly associated with lower odds of upstaging to pathological (p)T3+ disease (odds ratio [OR] 0.32, 95% confidence interval [CI] 0.12-0.82; P = 0.02), any upstaging (OR 0.41, 95% CI 0.20-0.83; P = 0.01), and any upstaging and/or pN+ (OR 0.50, 95% CI 0.25-1.00; P = 0.05). Luminal favourable bladder cancer was significantly associated with better OS (hazard ratio 0.33, 95% CI 0.15-0.74; P = 0.007).</p><p><strong>Conclusions: </strong>This study validates the performance of the GC for identifying UCs with a luminal favourable subtype, harbouring less aggressive tumour biology.</p>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142557099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care. 揭开医学科学出版的演变之谜,让科学为更好的病人护理带来希望。
IF 3.7 2区 医学
BJU International Pub Date : 2024-10-28 DOI: 10.1111/bju.16573
Riccardo Bertolo, Riccardo Campi, Nicholas G Zaorsky, Alessandro Antonelli, Sergio Serni, Alessandro Crestani, Gianluca Giannarini
{"title":"Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care.","authors":"Riccardo Bertolo, Riccardo Campi, Nicholas G Zaorsky, Alessandro Antonelli, Sergio Serni, Alessandro Crestani, Gianluca Giannarini","doi":"10.1111/bju.16573","DOIUrl":"https://doi.org/10.1111/bju.16573","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer. 前列腺癌放射治疗后膀胱癌根治性切除术患者的死亡率。
IF 3.7 2区 医学
BJU International Pub Date : 2024-10-27 DOI: 10.1111/bju.16571
Mario de Angelis, Carolin Siech, Francesco Di Bello, Natali Rodriguez Peñaranda, Jordan A Goyal, Zhe Tian, Nicola Longo, Felix K H Chun, Stefano Puliatti, Fred Saad, Shahrokh F Shariat, Giorgio Gandaglia, Marco Moschini, Mattia Longoni, Francesco Montorsi, Alberto Briganti, Pierre I Karakiewicz
{"title":"Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer.","authors":"Mario de Angelis, Carolin Siech, Francesco Di Bello, Natali Rodriguez Peñaranda, Jordan A Goyal, Zhe Tian, Nicola Longo, Felix K H Chun, Stefano Puliatti, Fred Saad, Shahrokh F Shariat, Giorgio Gandaglia, Marco Moschini, Mattia Longoni, Francesco Montorsi, Alberto Briganti, Pierre I Karakiewicz","doi":"10.1111/bju.16571","DOIUrl":"https://doi.org/10.1111/bju.16571","url":null,"abstract":"<p><strong>Objective: </strong>To conduct a population-based study examining cancer-specific mortality (CSM) and other-cause mortality (OCM) differences in patients with radiation-induced secondary bladder cancer (RT-BCa) vs those with primary bladder cancer (pBCa) undergoing radical cystectomy (RC).</p><p><strong>Methods: </strong>Within the Surveillance, Epidemiology, and End Results database (2004-2020), we identified patients with T<sub>2-4</sub>N<sub>0-3</sub>M<sub>0</sub> bladder cancer treated with RC, who had previously been treated with external beam radiation therapy (EBRT) or brachytherapy for prostate cancer, as well as patients with T<sub>2-4</sub>N<sub>0-3</sub>M<sub>0</sub> pBCa treated with RC. Cumulative incidence plots and multivariable competing risks regression (CRR) models were used to assess CSM after additional adjustment for OCM. The same methodology was then repeated based on organ-confined (OC: T<sub>2</sub>N<sub>0</sub>M<sub>0</sub>) and non-organ-confined (NOC: T<sub>3-4</sub> and/or N<sub>1-3</sub>) disease.</p><p><strong>Results: </strong>Of 9957 RC patients, RT-BCa was identified in 347 (3%) compared with 9610 (97%) who had pBCa. In multivariable CRR models, no CSM differences were recorded in the overall comparison (P = 0.8), nor in sub-groups based on OC and NOC disease (P = 0.8 and 0.7, respectively). Conversely, multivariable CRR models identified RT-BCa as an independent predictor of 1.3-fold higher OCM in the overall cohort and of 1.5-fold higher OCM in those with NOC disease. In a sensitivity analysis of patients with NOC disease, EBRT was associated with higher OCM rates (hazard ratio 1.5). By contrast, OCM rates were not different in those with OC disease (P = 0.8).</p><p><strong>Conclusion: </strong>Our study showed that RC for RT-BCa was associated with similar CSM rates as RC for pBCa, regardless of disease stage. However, patients who had undergone EBRT exhibited significantly higher OCM in the NOC sub-group.</p>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial 膀胱肿瘤整体切除术与传统经尿道膀胱肿瘤切除术的国际多中心随机对照试验:膀胱尿路上皮癌整体切除术(EBRUC)II 试验的初步结果
IF 4.5 2区 医学
BJU International Pub Date : 2024-10-27 DOI: 10.1111/bju.16543
Julian Peter Struck, Nadim Moharam, Armin Leitenberger, Jörg Weber, Lukas Lusuardi, David Oswald, Jens J. Rassweiler, Marcel Fiedler, Jakub Horňák, Marek Babjuk, Salvatore Micali, Carlo Zaraca, Thomas Spreu, Frank Friedersdorff, Hendrik Borgmann, Axel S. Merseburger, Mario W. Kramer
{"title":"An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial","authors":"Julian Peter Struck, Nadim Moharam, Armin Leitenberger, Jörg Weber, Lukas Lusuardi, David Oswald, Jens J. Rassweiler, Marcel Fiedler, Jakub Horňák, Marek Babjuk, Salvatore Micali, Carlo Zaraca, Thomas Spreu, Frank Friedersdorff, Hendrik Borgmann, Axel S. Merseburger, Mario W. Kramer","doi":"10.1111/bju.16543","DOIUrl":"https://doi.org/10.1111/bju.16543","url":null,"abstract":"ObjectivesTo determine the safety and oncological advantages of <jats:italic>en bloc</jats:italic> resection of bladder tumour (ERBT) vs conventional transurethral resection of bladder tumour (cTURBT) in terms of resection quality, staging quality, and safety.Patients and MethodsWe conducted a single‐blinded randomised controlled trial at seven European hospitals with the following inclusion criteria: first diagnosis of non‐muscle‐invasive bladder cancer, no singular carcinoma <jats:italic>in situ</jats:italic>, and tumour size &gt;4.3 mm. Patients were randomised intraoperatively in a 1:1 ratio to either the ERBT or cTURBT group. Outcome analysis was performed using the chi‐square test, <jats:italic>t</jats:italic>‐test, and multivariate regression analysis.ResultsA total of 97 patients were randomised into the study (cTURBT = 40, ERBT = 57). A switch to cTURBT was necessary in two patients (3.5%) and 11.5% of the screened patients were preoperatively excluded for ERBT. There was no difference in the specimen presence of detrusor muscle with 73.7% in cTURBT and 67.3% in ERBT specimens (<jats:italic>P</jats:italic> = 0.69). There were no significant differences in mean operative time (ERBT 27.6 vs cTURBT 25.4 min, <jats:italic>P</jats:italic> = 0.450) or mean resection time (ERBT 16.3 vs cTURBT 15.5 min, <jats:italic>P</jats:italic> = 0.732). Overall the complication rate did not differ significantly (ERBT 18.2% vs cTURBT 7.5%, <jats:italic>P</jats:italic> = 0.142). Bladder perforations occurred significantly more often in the ERBT group (ERBT seven vs cTURBT none, <jats:italic>P</jats:italic> = 0.020). R0 status was reported more often after ERBT, whilst a second resection was significantly less frequent after ERBT (<jats:italic>P</jats:italic> = 0.018). Recurrence rates were comparable for both techniques after 6 months of follow‐up.ConclusionThe feasibility of ERBT is higher than previously reported. Whereas other perioperative and safety parameters are comparable to cTURBT, bladder perforations occurred significantly more often in the ERBT group and raised safety concerns. This is why this trial was terminated.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical determination of the natural distensibility of the human ureter: initial study 人体输尿管自然伸缩性的临床测定:初步研究
IF 4.5 2区 医学
BJU International Pub Date : 2024-10-26 DOI: 10.1111/bju.16564
Sohrab N. Ali, Amanda McCormac, Andrei D. Cumpanas, Jaime Altamirano-Villarroel, Paul Piedras, Minh-Chau Vu, Andrew S. Afyouni, Zachary E. Tano, Kathryn Osann, Michael Klopfer, Pengbo Jiang, Roshan M. Patel, Jaime Landman, Ralph V. Clayman
{"title":"Clinical determination of the natural distensibility of the human ureter: initial study","authors":"Sohrab N. Ali, Amanda McCormac, Andrei D. Cumpanas, Jaime Altamirano-Villarroel, Paul Piedras, Minh-Chau Vu, Andrew S. Afyouni, Zachary E. Tano, Kathryn Osann, Michael Klopfer, Pengbo Jiang, Roshan M. Patel, Jaime Landman, Ralph V. Clayman","doi":"10.1111/bju.16564","DOIUrl":"https://doi.org/10.1111/bju.16564","url":null,"abstract":"To define the natural distensibility of the human ureter and evaluate the impact of other possibly favourable factors on ureteric distensibility.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cumulative re‐operation rates during follow‐up after hypospadias repair 尿道下裂修补术后随访期间的累积再手术率
IF 4.5 2区 医学
BJU International Pub Date : 2024-10-26 DOI: 10.1111/bju.16562
Ali Atan, Kaan Sonmez, Ramazan Karabulut, Zafer Turkyilmaz
{"title":"Cumulative re‐operation rates during follow‐up after hypospadias repair","authors":"Ali Atan, Kaan Sonmez, Ramazan Karabulut, Zafer Turkyilmaz","doi":"10.1111/bju.16562","DOIUrl":"https://doi.org/10.1111/bju.16562","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to the letter by Atan, Sonmez, Karabulut and Turkyilmaz 对 Atan、Sonmez、Karabulut 和 Turkyilmaz 来信的答复
IF 4.5 2区 医学
BJU International Pub Date : 2024-10-26 DOI: 10.1111/bju.16563
Niklas Pakkasjärvi, Annaleena Anttila, Seppo Taskinen
{"title":"Reply to the letter by Atan, Sonmez, Karabulut and Turkyilmaz","authors":"Niklas Pakkasjärvi, Annaleena Anttila, Seppo Taskinen","doi":"10.1111/bju.16563","DOIUrl":"https://doi.org/10.1111/bju.16563","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary retroperitoneal lymph node dissection in stage II testicular seminoma: a systematic review II期睾丸精原细胞瘤的原发性腹膜后淋巴结清扫:系统性综述
IF 4.5 2区 医学
BJU International Pub Date : 2024-10-25 DOI: 10.1111/bju.16536
Jianliang Liu, Mrunal Hiwase, Dixon T.S. Woon, Benjamin Thomas, Ben Tran, Nathan Lawrentschuk
{"title":"Primary retroperitoneal lymph node dissection in stage II testicular seminoma: a systematic review","authors":"Jianliang Liu, Mrunal Hiwase, Dixon T.S. Woon, Benjamin Thomas, Ben Tran, Nathan Lawrentschuk","doi":"10.1111/bju.16536","DOIUrl":"https://doi.org/10.1111/bju.16536","url":null,"abstract":"ObjectiveTo conduct a systematic review of the current literature to determine the current role of primary retroperitoneal lymph node dissection (RPLND) in stage II testicular seminoma and its associated oncological, functional and peri‐operative outcomes.Materials and MethodsA comprehensive literature search was conducted in Medline, Embase, and Scopus for publications from inception until November 2023. The systematic review was registered on PROSPERO (ID CRD42023449781), was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines and utilised the Methodological Index for Non‐Randomised Studies (MINORS) tool.ResultsSix studies involving 385 patients were analysed, with 48.5% clinical stage IIA and 51.5% stage IIB seminomas. The patients’ mean (range) age was 37 (20–64) years. The median operation time was 187 min, median estimated blood loss was 150 mL and median length of hospital stay was 4 days. In all, 6.1% of patients developed complications that were greater or equal to Clavien–Dindo grade 3. Only four studies reported on anejaculation rate (median: 4.9%). Only one study had long‐term data, demonstrating a 92% 5‐year overall survival for stage IIA/B disease treated with RPLND. The remaining five studies had a median follow‐up of between 18.5 and 37 months and reported a mean recurrence rate of 15.6%. Most recurrences (78%) were not within the field of RPLND. Recurrence was associated with higher clinical and pathological lymph node stage, and metachronous or delayed development of retroperitoneal lymphadenopathy (initially stage I disease, as opposed to <jats:italic>de novo</jats:italic> stage IIA/B disease).DiscussionPrimary RPLND, performed by experienced surgeons, has good peri‐operative outcomes. Recurrence is more common than with standard treatment, but long‐term survival and functional data are limited, although promising.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between renal pelvis pressure and post‐ureteroscopy infection in a live swine model 活体猪模型中肾盂压力与输尿管镜检查后感染之间的关系
IF 4.5 2区 医学
BJU International Pub Date : 2024-10-25 DOI: 10.1111/bju.16539
David Hinojosa‐Gonzalez, Christina Kottooran, Jennifer Saunders, Erin L. Chaussee, Jay Budrewicz, Brian H. Eisner
{"title":"Relationship between renal pelvis pressure and post‐ureteroscopy infection in a live swine model","authors":"David Hinojosa‐Gonzalez, Christina Kottooran, Jennifer Saunders, Erin L. Chaussee, Jay Budrewicz, Brian H. Eisner","doi":"10.1111/bju.16539","DOIUrl":"https://doi.org/10.1111/bju.16539","url":null,"abstract":"ObjectiveTo evaluate the relationship between renal pelvis pressure and infection after ureteroscopy, using a live swine model.Materials and MethodsIn anaesthetised pigs, a 1‐h ureteroscopy was performed using a pressure‐sensing guidewire, with renal pelvis pressure maintained at either 37 mmHg or 75 mmHg for the entire procedure and infusion with saline alone or with a standardised concentration of uropathogenic <jats:italic>Escherichia coli</jats:italic> strain CFT073 (1.5 × 10<jats:sup>7</jats:sup> colony‐forming units [CFU]/mL). Venous blood sampling was performed during and after the procedure. Vital signs, inflammatory biomarkers, and renal tissue and blood cultures were assessed.ResultsIn 21 pig kidneys, study groups were: 37 mmHg with saline irrigation (<jats:italic>n</jats:italic> = 3); 75 mmHg with saline irrigation (<jats:italic>n</jats:italic> = 4); 37 mmHg with saline irrigation with 1.5 × 10<jats:sup>7</jats:sup> CFU/mL <jats:italic>E. coli</jats:italic> (<jats:italic>n</jats:italic> = 7); and 75 mmHg with saline irrigation with 1.5 × 10<jats:sup>7</jats:sup> CFU/mL <jats:italic>E. coli</jats:italic> (<jats:italic>n</jats:italic> = 7). Statistically significant changes in inflammatory biomarkers were most pronounced in the group with 75 mmHg saline irrigation + <jats:italic>E. coli</jats:italic> and were significantly elevated compared with the control group and the group receiving <jats:italic>E. coli</jats:italic> irrigation at 37 mmHg. Positive blood cultures were noted in 5/7 animals treated with <jats:italic>E. coli</jats:italic> at 75 mmHg; no others developed bacteraemia.ConclusionIn this swine model of ureteroscopy, irrigation with saline + <jats:italic>E. coli</jats:italic> at a renal pelvis pressure of 75 mmHg resulted in bacteraemia and inflammatory biomarker elevations significantly greater than both <jats:italic>E. coli</jats:italic> irrigation with renal pelvis pressure maintained at 37 mmHg and the control.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insurance remains a major source of disparity for patients with testicular cancer: call for advocacy 保险仍是造成睾丸癌患者不平等的主要原因:呼吁宣传
IF 4.5 2区 医学
BJU International Pub Date : 2024-10-25 DOI: 10.1111/bju.16568
Savannah Starr, Jj Zhang, Lin Lin, Jolie Shen, Giovanni Gamalong, Mark S. Litwin, Alexandra Drakaki, Karim Chamie
{"title":"Insurance remains a major source of disparity for patients with testicular cancer: call for advocacy","authors":"Savannah Starr, Jj Zhang, Lin Lin, Jolie Shen, Giovanni Gamalong, Mark S. Litwin, Alexandra Drakaki, Karim Chamie","doi":"10.1111/bju.16568","DOIUrl":"https://doi.org/10.1111/bju.16568","url":null,"abstract":"To evaluate the effects of socioeconomic factors, including insurance status, on treatment and survival for patients with testicular cancer.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信